M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Assessment of fatigue in the management of patients with ankylosing spondylitis
TL;DR: It is suggested that fatigue should be considered as an independent domain to be systematically evaluated in ankylosing spondylitis patients and that conventional therapy such as NSAIDs have a lower effect on this domain than on pain or functional impairment.
Journal ArticleDOI
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008
Monika Schoels,Daniel Aletaha,Josef S. Smolen,Johannes W. J. Bijlsma,Gerd R Burmester,Ferdinand C. Breedveld,Maurizio Cutolo,Bernard Combe,Maxime Dougados,Paul Emery,Joachim R. Kalden,Edward C. Keystone,Tore K Kvien,Emilio Martín-Mola,Carlomaurizio Montecucco,Maarten de Wit +15 more
TL;DR: These results suggest the acceptance of ambitious treatment concepts in practice, and reflect widespread adoption of desirable standards of care, in practice.
Journal ArticleDOI
Diagnosis of vertebral fractures by vertebral fracture assessment.
TL;DR: Vertebral fracture assessment is a reliable technique with low radiation, and is easily and rapidly applicable during bone density measurement by DXA, which could improve management of osteoporotic patients.
Journal ArticleDOI
Significant linkage to spondyloarthropathy on 9q31–34
Corinne Miceli-Richard,Habib Zouali,Roula Said-Nahal,Suzanne Lesage,Françoise Merlin,Claudia de Toma,Hélène Blanché,Mourad Sahbatou,Maxime Dougados,Gilles Thomas,Maxime Breban,Jean-Pierre Hugot,Groupe Français d'Etude Génétique des Spondylarthropathies +12 more
TL;DR: Evidence is provided for the presence of a non-MHC susceptibility locus for SpA mapping to 9q31-34, in the vicinity of marker D9S1776.
Journal Article
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
John C. Davis,Désirée van der Heijde,Maxime Dougados,Jürgen Braun,John J. Cush,Daniel O. Clegg,Robert D. Inman,Todd de Vries,Wayne Tsuji +8 more
TL;DR: Higher CRP values and back pain scores and lower BASFI scores at baseline were significant predictors of a higher ASAS 20 response in patients with ankylosing spondylitis receiving etanercept but predictive value was of insufficient magnitude to determine treatment in individual patients.